Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

L. Moreno, M. Casanova, J.C. Chisholm, P. Berlanga, P.B. Chastagner, S. Baruchel, L. Amoroso, S.G. Melcón, N.U. Gerber, G. Bisogno, F. Fagioli, B. Geoerger, J.L. Glade Bender, I. Aerts, C. Bergeron, P. Hingorani, I. Elias, M. Simcock, S. Ferrara, Y. Le BruchecR. Slepetis, N. Chen, G. Vassal

Research output: Contribution to journalArticle

Cite this

Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Melcón, S. G., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., ... Vassal, G. (2018). Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. European journal of cancer, 100, 27-34. https://doi.org/10.1016/j.ejca.2018.05.002